IP Verse

Combination Medicament Comprising Il-12 And An Agent For Blockade Of T-Cell Inhibitory Molecules For Tumour Therapy

PatentPatent Analysis

EP3351261

UNIVERSITT ZRICH
Application Number
EP18160057A
Filing Date
Oct 10, 2012
Status
Granted And Under Opposition
Apr 30, 2021
Grant Date
Jun 2, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3169797B2
EP3487295B1
EP2979096B1

Bibliography

The patent EP3351261B1 was granted to Universitt Zrich on Jun 2, 2021 following the initial filing on Oct 10, 2012 under the application number EP18160057A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMar 2, 2022ADMISSIBLE
KRAUS & LEDERER PARTGMBBMar 2, 2022ADMISSIBLE
WEINZIERLMar 2, 2022ADMISSIBLE
SANOFIMar 2, 2022WITHDRAWN
JG OPPOSITIONSMar 1, 2022ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents